Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
The ALBI score appears to be a useful non-invasive marker for assessing liver fibrosis in chronic HCV patients and may serve as a valuable tool for monitoring hepatic function during and after DAA treatment.
Authors
- Mohammed Ewid (ORCID: https://orcid.org/0000-0001-8118-6975)
- Ziyad T. Ahmed (ORCID: https://orcid.org/0000-0001-6737-0194)
- Ammar Alammari (ORCID: https://orcid.org/0000-0003-1413-9604)
- Nawaf Al Mutiri
- Nazmus Saquib (ORCID: https://orcid.org/0000-0002-2819-2839)
- Mohammed H. Alkahlot (ORCID: https://orcid.org/0009-0009-3849-2315)
- Amro Abdelaziz Mohammed Ismail
- Hossam Sherif
- Faisal Zain Mohammed Al-Zabidi
Institutions
- Cairo University (EG)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.4254/wjh.v17.i9.110049
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00